Literature DB >> 20023388

Pinpointing Pin1 in non-small cell lung carcinoma.

Joseph Catanzaro1, Wei-Xing Zong.   

Abstract

Factors that promote tumorigenesis encompass a wide array of proteins that include transcription factors, signal transduction molecules, negative regulators of tumor suppressors, transmembrane receptors and enzymes involved in a variety of processes. Identifying these factors remains one of the most pertinent issues in cancer research, as they can be used as both diagnostic markers and therapeutic targets. The ability to characterize tumors based on molecular markers will enable one to easily assess tumor severity, select a method of treatment and ultimately improve patient outcome. While the treatment of primary tumors has improved by leaps and bounds over the past decade, metastases continue to plague both patients and the research community. Along these lines, markers that predict metastatic potential will help to both limit secondary tumor growths and improve patient outcome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20023388      PMCID: PMC3132472          DOI: 10.4161/cbt.9.2.10767

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  11 in total

Review 1.  Metastasis-suppressor genes: a review and perspective on an emerging field.

Authors:  B A Yoshida; M M Sokoloff; D R Welch; C W Rinker-Schaeffer
Journal:  J Natl Cancer Inst       Date:  2000-11-01       Impact factor: 13.506

2.  Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation.

Authors:  Takafumi Uchida; Mari Takamiya; Morito Takahashi; Hitoshi Miyashita; Hisafumi Ikeda; Toru Terada; Yo Matsuo; Mikako Shirouzu; Shigeyuki Yokoyama; Fumihiro Fujimori; Tony Hunter
Journal:  Chem Biol       Date:  2003-01

3.  Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.

Authors:  G M Wulf; A Ryo; G G Wulf; S W Lee; T Niu; V Petkova; K P Lu
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

Review 4.  The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease.

Authors:  Kun Ping Lu; Xiao Zhen Zhou
Journal:  Nat Rev Mol Cell Biol       Date:  2007-11       Impact factor: 94.444

5.  Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases.

Authors:  Jie He; Fang Zhou; Kang Shao; Jie Hang; Hui Wang; Elizabeth Rayburn; Zhi-xiong Xiao; Sam W Lee; Qi Xue; Xiao-li Feng; Su-sheng Shi; Cui-yan Zhang; Sen Zhang
Journal:  Lung Cancer       Date:  2007-02-02       Impact factor: 5.705

6.  Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells.

Authors:  Mi Ra Kim; Hoo-Kyun Choi; Kyoung Bin Cho; Hyung Sik Kim; Keon Wook Kang
Journal:  Cancer Sci       Date:  2009-07-24       Impact factor: 6.716

Review 7.  Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.

Authors:  T Hunter; J Pines
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

8.  Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer.

Authors:  Akihide Ryo; Hiroji Uemura; Hitoshi Ishiguro; Tatsuya Saitoh; Akira Yamaguchi; Kilian Perrem; Yoshinobu Kubota; Kun Ping Lu; Ichiro Aoki
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

9.  Pin1 expression contributes to lung cancer: Prognosis and carcinogenesis.

Authors:  Xiaogang Tan; Fang Zhou; Junting Wan; Jie Hang; Zhaoli Chen; Baozhong Li; Cuiyan Zhang; Kang Shao; Peng Jiang; Susheng Shi; Xiaoli Feng; Ning Lv; Zhen Wang; Yun Ling; Xiaohong Zhao; Dapeng Ding; Jian Sun; Meihua Xiong; Jie He
Journal:  Cancer Biol Ther       Date:  2010-01-17       Impact factor: 4.742

10.  Prevalent overexpression of prolyl isomerase Pin1 in human cancers.

Authors:  Lere Bao; Amy Kimzey; Guido Sauter; Janusz M Sowadski; Kun Ping Lu; Da-Gong Wang
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.